The first real-world study evaluating the effectiveness of newly approved respiratory syncytial virus (RSV) vaccines in adults aged 60 years and older found that vaccinated participants had lower rates of RSV infection than unvaccinated…
Early Real-World Data Suggest RSV Vaccination May Reduce Infection Risk in Older Adults
